Novartis AG (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 164   

Articles published

NVS 79.38 -0.26 (-0.33%)
price chart
Novartis AG (ADR) (NYSE:NVS) Says A Picture Is Worth A Thousand Words
How do you mix medicine and photography? That's what Novartis AG (ADR) (NYSE:NVS) is doing and it feels nothing strange about it.
Novartis AG (NYSE:NVS) Fights for Survival after Patent Expiration  TCC
Here's What's Important With The Novartis AG (ADR) (NVS) MS Data  Insider Monkey (blog)
Novartis AG (ADR) (NYSE:NVS): Reviewing Earnings Estimates
Novartis AG (ADR) (NYSE:NVS) soared 0.51% or +0.42 points during previous trade after opening at the price of $81.92, a total of 1.58M shares exchanged hands compared with its average trading volume of 1.71M shares.
HC Stocks Updates: Envision Healthcare Holdings Inc (NYSE:EVHC) Novartis AG ...  share market updates (press release)
Will Novartis AG (ADR) (NVS) Clinch Biosimilar Market by 2020?
Novartis AG's (ADR)(NYSE:NVS) biosimilar and generic division, Sandoz is working for the development of novel biosimilars versions of the blockbuster drugs to patch up the revenue loss of its blockbuster drugs' patents.
Novartis AG (ADR) (NYSE:NVS) To Pay $25 Million Over Bribery Allegations
Last year GlaxoSmithKline plc (ADR) (NYSE:GSK) posted a 17% drop in sales as a state-led campaign on drug prices affected returns.
Will Novartis AG (ADR) (NVS) be Forbidden in Korea after Bribe Charges?
Novartis AG (ADR) (NYSE:NVS) is hit by bad news of involvement of its six senior officials under the charges of corruption.
How Many Heart Failure Deaths Can Novartis AG (ADR) (NYSE:NVS) Entresto Reduce?
A fresh analysis of Novartis AG (ADR) (NYSE:NVS) drug Entresto has shown that it can significantly reduce heart failure deaths.
Bryn Mawr Trust Company Decreased Stake in Novartis Ag Sponsored Adr (NYSE:NVS ...
Bryn Mawr Trust Company decreased its stake in Novartis Ag Sponsored Adr (NYSE:NVS) by 68.65% based on its latest 2016Q2 regulatory filing with the SEC.
Xencor Inc (NASDAQ:XNCR) to Collaborate with Pharma Giant Novartis AG (ADR ...
Xencor Inc (NASDAQ:XNCR) shares rose 32.06% to $16.56 on Tuesday after the company officially signed its collaboration agreement with Novartis AG (ADR) (NYSE:NVS), which has agreed to pay $150 million to have access to Xencor's top two product ...
Novartis AG (NYSE:NVS) Betting On Xencor's Two Drug Candidates With $2.4 ...  Market Exclusive
Hedge Funds Aren't Crazy About Novartis AG (ADR) (NVS) Anymore
We can judge whether Novartis AG (ADR) (NYSE:NVS) is a good investment right now by following the lead of some of the best investors in the world and piggybacking their ideas.
Bimagrumab (BYM338) drug from Novartis AG (ADR) (NYSE:NVS) Failed a Phase IIb ...
Bimagrumab (BYM338) from Novartis AG (ADR) (NYSE:NVS) failed a Phase IIb/III study. The news of the failure of the study pertaining to a rare, muscle-wasting disease known as sporadic inclusion body myositis was heartbreaking for the pharma giant since ...